Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Carcinoma (EC)”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableNot Yet RecruitingNCT07374809
What this trial is testing

IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER

Who this might be right for
Endometrial Carcinoma (EC)pMMRDMMR Cancer
European Institute of Oncology 50
Not applicableStudy completedNCT02834988
What this trial is testing

Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Miami 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT06129604
What this trial is testing

Pilot Window of Opportunity Trial (POET)

Who this might be right for
Colorectal Carcinoma (CRC)Endometrial Carcinoma (EC)
University of Oklahoma 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897527
What this trial is testing

Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100
Testing effectiveness (Phase 2)WithdrawnNCT05483023
What this trial is testing

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Early research (Phase 1)Active Not RecruitingNCT05277051
What this trial is testing

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 152
Testing effectiveness (Phase 2)Looking for participantsNCT07377734
What this trial is testing

Intrauterine Injection of Type III Collage in FST of EC/AEH

Who this might be right for
Atypical Endometrial HyperplasiaEndometrial Cancer
Wang Jianliu 30
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Not applicableLooking for participantsNCT06893861
What this trial is testing

Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer

Who this might be right for
Endometrial Carcinoma (EC)
National Cancer Institute, Naples 3,100
Not applicableStudy completedNCT06192017
What this trial is testing

Development of a Molecular Diagnostic Tool for Endometrial Cancer.

Who this might be right for
Endometrium Cancer
MiMARK Diagnostics, S.L. 1,950
Large-scale testing (Phase 3)Looking for participantsNCT05611931
What this trial is testing

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Karyopharm Therapeutics Inc 276
Testing effectiveness (Phase 2)Study completedNCT02035787
What this trial is testing

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03835819
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

Who this might be right for
Endometrial Cancer
Dana-Farber Cancer Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT06914297
What this trial is testing

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

Who this might be right for
Endometrial Cancer
Fudan University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05669430
What this trial is testing

GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor, AdultRefractory CancerEndometrial Carcinoma (EC)+4 more
GV20 Therapeutics 365
Testing effectiveness (Phase 2)Looking for participantsNCT06925724
What this trial is testing

Ivonescimab in People With Endometrial and Cervical Cancers

Who this might be right for
Endometrial CancerCervical Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT07108270
What this trial is testing

Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 30
Not applicableNot Yet RecruitingNCT07006103
What this trial is testing

Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification

Who this might be right for
Endometrial Cancer, Endometrial Neoplasm
Hospital Italiano de Buenos Aires 400
Large-scale testing (Phase 3)Looking for participantsNCT03463252
What this trial is testing

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Who this might be right for
Endometrial CancerAtypical Endometrial Hyperplasia
West China Second University Hospital 224
Load More Results